New Multiple Myeloma Drug Shows Promise in Treating People with Advanced Disease
Monday, December 10, 2012 - 13:01
in Health & Medicine
A new oral agent under review by the U.S. Food and Drug Administration (FDA) is safe and effective in treating relapsed and treatment-resistant multiple myeloma, according to a multicenter, Phase II study presented by Mount Sinai School of Medicine researchers at the American Society of Hematology (ASH) Annual Meeting.